Angiotensin II receptor blockade: A novel strategy to prevent immunosuppressant-associated cancer progression

Transplantation Proceedings

Volumn 33, Issue 1-2, 2001, Pages 1820-1821

  Maluccio, M ^a   Sharma, V ^a   Lagman, M ^a   Konijn, G ^a   Suthanthiran, M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; CYCLOSPORIN; LOSARTAN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; KIDNEY CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CARCINOMA, RENAL CELL; CYCLOSPORINE; IMMUNOSUPPRESSIVE AGENTS; LOSARTAN; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; MICE, SCID; RECEPTORS, ANGIOTENSIN;

EID: 0035082574     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)02696-8     Document Type: Article

References (5)

1. Hojo M, Morimoto T, Maluccio M, et al: Nature 397:530, 1999
2. 1 by cyclosporine. FEBS Lett 358:109, 1995
3. Avdonin P, Cottet-Maire F, Afanasjeva G, et al: Kidney Int 55:2407, 1999
4. Siegert A, Ritz E, Orth S, Wagner J: J Mol Med 77:437, 1999
5. Takeuchi K, Nakamura N, Cook NS, et al: Biochem Biophys Res Commun 172:1189, 1990